Cargando…
Suramin Affects the Renal VEGF-A/VEGFR Axis in Short-Term Streptozotocin-Induced Diabetes
Diabetic nephropathy (DN) accounts for approximately 50% of end-stage renal diseases. Vascular endothelial growth factor A (VEGF-A) is thought to be a critical mediator of vascular dysfunction in DN, but its role is unclear. The lack of pharmacological tools to modify renal concentrations further hi...
Autores principales: | Chyła-Danił, Gabriela, Sałaga-Zaleska, Kornelia, Kreft, Ewelina, Krzesińska, Aleksandra, Herman, Sylwia, Kuchta, Agnieszka, Sakowicz-Burkiewicz, Monika, Lenartowicz, Małgorzata, Jankowski, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053825/ https://www.ncbi.nlm.nih.gov/pubmed/36986570 http://dx.doi.org/10.3390/ph16030470 |
Ejemplares similares
-
Long-Term Effects of Suramin on Renal Function in Streptozotocin-Induced Diabetes in Rats
por: Chyła-Danił, Gabriela, et al.
Publicado: (2023) -
Suramin enhances the urinary excretion of VEGF-A in normoglycemic and streptozotocin-induced diabetic rats
por: Chyła, Gabriela, et al.
Publicado: (2021) -
Redox regulation of hemodynamics response to diadenosine tetraphosphate an agonist of P2 receptors and renal function in diet‐induced hypercholesterolemic rats
por: Dąbkowski, Kamil, et al.
Publicado: (2021) -
Lipid Profile, Lp(a) Levels, and HDL Quality in Adolescents with Down Syndrome
por: Krzesińska, Aleksandra, et al.
Publicado: (2022) -
Nanoparticle Tracking Analysis of Urinary Extracellular Vesicle Proteins as a New Challenge in Laboratory Medicine
por: Sałaga-Zaleska, Kornelia, et al.
Publicado: (2023)